Highly active antiretroviral therapy (HAART) has been shown to decrease plasma and CSF viral load, delay the onset of immunosuppression and improve cognitive function in HIV-infected individuals. However, HAART has been less effective in lowering virus replication in the CNS as demonstrated by studies showing modest to no reduction in CSF viral load in patients on HAART despite dramatic reductions in plasma virus load. Further, two comprehensive autopsy studies of 740 HIV-infected individuals found no change in the incidence of CNS inflammatory lesions since 1996, when HAART was first introduced. These data suggest that antiretroviral therapy does not completely suppress virus replication in the CNS, nor the accompanying inflammatory changes. It is difficult to comprehensively examine the effects of antiretroviral therapy on CNS virus replication and inflammation in HIV-infected individuals because early and ongoing events in the CNS cannot be directly examined. The SIV/macaque model is an ideal system in which to examine the effects of antiretroviral therapy on the CNS during both acute and long term infection. The proposed studies will determine, in an SIV model that consistently causes SIV encephalitis, whether antiretroviral therapy that effectively suppresses systemic virus replication also suppresses CNS virus replication and inflammation. Our hypothesis is that antiretroviral therapy that effectively lowers viral load in the periphery does not abrogate virus replication or the accompanying inflammatory changes in the CNS.
Our Aims are: 1 a ) To determine whether CNS virus replication is suppressed in macaques treated with antiretroviral therapy that effectively suppresses plasma viral load. 1 b) To determine whether antiretroviral therapy that suppresses plasma viral load also suppresses virus replication in specific target cells in the CNS, including macrophages, microglia, lymphocytes, astrocytes, and neurons. 1 c) To determine whether antiretroviral therapy that suppresses plasma viral load also suppresses CNS inflammation in the brains of SIV-infected macaques as measured by infiltration of macrophages into the CNS, activation of astrocytes and microglial cells, and production of chemokines and expression cell adhesion molecules on endothelial cells. 2) To determine whether antiretroviral therapy that suppresses virus replication in the periphery modulates the selection and replication of neurovirulent viruses in the CNS of SIV-infected macaques.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS044815-03
Application #
6753563
Study Section
Special Emphasis Panel (ZRG1-AARR-1 (05))
Program Officer
Nunn, Michael
Project Start
2002-08-01
Project End
2006-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
3
Fiscal Year
2004
Total Cost
$498,245
Indirect Cost
Name
Johns Hopkins University
Department
Veterinary Sciences
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Eugenin, Eliseo A; Clements, Janice E; Zink, M Christine et al. (2011) Human immunodeficiency virus infection of human astrocytes disrupts blood-brain barrier integrity by a gap junction-dependent mechanism. J Neurosci 31:9456-65
Roberts, Toni K; Eugenin, Eliseo A; Morgello, Susan et al. (2010) PrPC, the cellular isoform of the human prion protein, is a novel biomarker of HIV-associated neurocognitive impairment and mediates neuroinflammation. Am J Pathol 177:1848-60
Clements, Janice E; Mankowski, Joseph L; Gama, Lucio et al. (2008) The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment. J Neurovirol 14:309-17
Follstaedt, Susan C; Barber, Sheila A; Zink, M Christine (2008) Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1. J Neurovirol 14:376-88
Zink, M Christine; Laast, Victoria A; Helke, Kristi L et al. (2006) From mice to macaques--animal models of HIV nervous system disease. Curr HIV Res 4:293-305
Wachtman, Lynn M; Tarwater, Patrick M; Queen, Suzanne E et al. (2006) Platelet decline: an early predictive hematologic marker of simian immunodeficiency virus central nervous system disease. J Neurovirol 12:25-33
Helke, Kristi L; Queen, Suzanne E; Tarwater, Patrick M et al. (2005) 14-3-3 protein in CSF: an early predictor of SIV CNS disease. J Neuropathol Exp Neurol 64:202-8
Zink, M Christine; Uhrlaub, Jennifer; DeWitt, Jesse et al. (2005) Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293:2003-11
Clements, Janice E; Li, Ming; Gama, Lucio et al. (2005) The central nervous system is a viral reservoir in simian immunodeficiency virus--infected macaques on combined antiretroviral therapy: a model for human immunodeficiency virus patients on highly active antiretroviral therapy. J Neurovirol 11:180-9
Barber, Sheila A; Uhrlaub, Jennifer L; DeWitt, Jesse B et al. (2004) Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis. Am J Pathol 164:355-62